During clinical trials, new pharmaceuticals are often stored at very low temperatures and marked with variable data later in the process. Additional marking of drugs stored at temperatures of below 4° F posed a challenge, because condensation would form on a conventional label immediately after being removed from the freezer. The water from the condensation had to be removed in a separate process before the label could be marked or an additional label could be applied.
The Pharma-Wrap label contains a transparent surface layer that prevents any kind of condensation from forming and protects the base label from abrasion and scratching. This allows for a second smaller label containing the variable data to be applied immediately after removing the product from the freezer.
Another benefit in using the Pharma-Wrap for clinical trials is that it has two detachable corners marked with a P for “placebo” and V for “active drug.” After applying the label, the operator can detach the corner that doesn’t apply to indicate, at a glance, whether it’s a placebo or an active drug.
Schreiner MediPharm is headquartered in Oberschleissheim, Germany. Its US facility is in Blauvelt, NY.